These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7184381)

  • 41. [Current problems in the diagnosis and treatment of myeloma disease].
    Alekseev GA
    Klin Med (Mosk); 1983 May; 61(5):8-12. PubMed ID: 6348403
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical concepts derived from animal chemotherapy studies.
    Goldin A; Schabel FM
    Cancer Treat Rep; 1981; 65 Suppl 3():11-9. PubMed ID: 7049366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Renal insufficiency and myeloma: therapeutic success in relation to reduction of tumor mass].
    Bondía Román A; San Miguel J; Guervos CS; Batlle F; Tabernero Romo JM; López-Borrasca A
    Rev Clin Esp; 1982 Feb; 164(3):191-2. PubMed ID: 7089337
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of myeloma disease].
    Verevkin IN
    Med Sestra; 1981 Nov; 40(11):5-7. PubMed ID: 6915349
    [No Abstract]   [Full Text] [Related]  

  • 45. [The multiple myeloma--current view and perspectives].
    Knop S
    Med Monatsschr Pharm; 2014 Mar; 37(3):84-92; quiz 93-4. PubMed ID: 24741848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative efficacy of chemotherapy in myeloma and cancer patients with relatively long survival].
    Iavorkovskiĭ LI; Soloveĭ DIa; Rastrigin VL; Riauzova LIu
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):11-3. PubMed ID: 7088915
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of chronic myeloid and lymphoid leukemias, and of multiple myeloma (author's transl)].
    Stryckmans P; Malarmé M
    Rev Med Brux; 1980 May; 1(5):307-10. PubMed ID: 6936745
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term survival in multiple myeloma.
    Lee BJ; Myers J
    N Engl J Med; 1983 Jul; 309(4):243-4. PubMed ID: 6866045
    [No Abstract]   [Full Text] [Related]  

  • 49. More promising treatment for multiple myeloma. Combinations of drugs may supplant current standards of care in view of new drug data.
    Duke Med Health News; 2010 Apr; 16(4):7. PubMed ID: 20491157
    [No Abstract]   [Full Text] [Related]  

  • 50. [Measures for infection in multiple myeloma].
    Horiuchi A; Azuma T
    Nihon Rinsho; 1995 Mar; 53(3):699-702. PubMed ID: 7699908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current status of chemotherapy of malignant diseases of the hematopoietic organs].
    Ducach G
    Rev Med Chil; 1970 May; 98(5):309-21. PubMed ID: 5478171
    [No Abstract]   [Full Text] [Related]  

  • 52. The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence.
    Hostenkamp G; Lichtenberg FR
    Soc Sci Med; 2015 Apr; 130():162-71. PubMed ID: 25703669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of plasma cell myeloma.
    Bergsagel DE
    Annu Rev Med; 1979; 30():431-43. PubMed ID: 162450
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of treatment and response status on infection risk in multiple myeloma.
    Perri RT; Hebbel RP; Oken MM
    Am J Med; 1981 Dec; 71(6):935-40. PubMed ID: 7315855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Initial therapy for multiple myeloma].
    Shimizu K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():589-96. PubMed ID: 23134020
    [No Abstract]   [Full Text] [Related]  

  • 56. Optimal control applications in the chemotherapy of multiple myeloma.
    Swan GW
    IMA J Math Appl Med Biol; 1985; 2(3):139-60. PubMed ID: 3870983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors and causes of early mortality in patients with newly diagnosed multiple myeloma in a "real-world" study: experiences of the Polish Myeloma Group.
    Charliński G; Tyczyńska A; Małecki B; Fornagiel S; Barchnicka A; Kołkowska A; Kopińska A; Usnarska-Zubkiewicz L; Robak P; Waszczuk-Gajda A; Krzystański M; Jurczyszyn A
    Pol Arch Intern Med; 2021 Jun; 131(6):527-534. PubMed ID: 33908731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Medical rehabilitation in ambulatory care of patients with myeloma].
    Mokeeva RA; Rybakova ME; Zaĭtseva AI; Polonskaia EN
    Gematol Transfuziol; 1983 Nov; 28(11):21-5. PubMed ID: 6654022
    [No Abstract]   [Full Text] [Related]  

  • 59. Myelomatosis: Current status and future prospects in pathology and treatment. In honour of Aage Videbaek. Copenhagen, November 1984.
    Scand J Haematol; 1985 Jul; 35(1):1-49. PubMed ID: 4048855
    [No Abstract]   [Full Text] [Related]  

  • 60. [Multiple myeloma: current status and future perspectives].
    Qiu LG; An G
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):649-51. PubMed ID: 22339819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.